Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes-Reference-Cited by-同舟云学术

Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes

Published:2020-12 Issue:3 Volume:159 Page:649-656
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Kortekaas Kim E.,Bastiaannet Esther,van Doorn Helena C.,de Vos van Steenwijk Peggy J.,Ewing-Graham Patricia C.,Creutzberg Carien L.,Akdeniz Kadir,Nooij Linda S.,van der Burg Sjoerd H.,Bosse Tjalling,van Poelgeest Mariette I.E.

Funder

KWF Kankerbestrijding

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference42 articles.

1. Trends in incidence and survival of Dutch women with vulvar squamous cell carcinoma;Schuurman;Eur. J. Cancer,2013

2. Trends in the incidence of invasive and in situ vulvar carcinoma;Judson;Obstet. Gynecol.,2006

3. Trends in HPV-dependent and HPV-independent vulvar cancers: the changing face of vulvar squamous cell carcinoma;Eva;Gynecol. Oncol.,2020

4. Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer;Gadducci;Crit. Rev. Oncol. Hematol.,2006

5. Revised FIGO staging for carcinoma of the vulva;Hacker;Int. J. Gynaecol. Obstet.,2009

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Whole-Exome Sequencing of Vulvar Squamous Cell Carcinomas Reveals an Impaired Prognosis in Patients With TP53 Mutations and Concurrent CCND1 Gains;Modern Pathology;2024-10

2. Review effects of radiation treatment on HPV-related vulvar cancer: a meta-analysis and systematic review;Frontiers in Oncology;2024-09-11

3. DNA Methylation and P53 Immunohistochemistry as Prognostic Biomarkers for Vulvar Lichen Sclerosus;Modern Pathology;2024-09

4. Simultaneous p53 and p16 Immunostaining for Molecular Subclassification of Head and Neck Squamous Cell Carcinomas;Head and Neck Pathology;2024-08-07

5. Advancements in siRNA delivery using nanotechnology for reproductive tract cancers: From targeting to enhancing treatment efficacy;Journal of Reproductive Healthcare and Medicine;2024-08-05